A.J. Straus, S.K. Kempelingaiah, S. Nguyen and colleagues reported in Cell Death Discovery that blocking glucosylceramide production can kill cancer cells through lysosomal dysfunction rather than through ceramide accumulation. The work frames glucosylceramide synthesis as a controlled vulnerability tied to cancer cell survival machinery. The study focuses on how perturbing specific membrane lipid biosynthesis disrupts intracellular organelle function, pushing malignant cells toward death. By distinguishing the mechanism from ceramide buildup, the results narrow the likely therapeutic target and inform follow-on compound optimization. For therapeutic development, the translational question is whether clinically tractable inhibitors can reproduce the lysosome-linked failure mode in tumors with sufficient selectivity.